Today: 19 July 2026
Browse Category

NYSE:TMO 8 December 2025 - 9 January 2026

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher Scientific Inc shares barely budged in after-hours trading — the stretch after the 4 p.m. close — despite a 1.7% dip in Thursday’s regular session that ended at $606.50. During the day, shares swung between $604 and $623.20, with trading volume swelling past 3 million shares, nearly double the 50-day average. Just two days before, on Tuesday, the stock had hit a 52-week high of $628.08. MarketWatch
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

Thermo Fisher Scientific Inc shares rose 3.2% to close at $611.20 on Monday, after trading between $590 and $611.60 and hitting a fresh 52-week high. Evercore ISI lifted its price target — an analyst estimate for where a stock could trade — to $650 from $610 and kept an “Outperform” rating, meaning it expects the shares to beat the broader market. Marketscreener data showed a consensus “Buy” rating and an average target price of $641.57. marketwatch.com+2Moomoo+2
6 January 2026
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific Inc shares rose about 2.4% in afternoon trading on Monday after Evercore ISI raised its price target to $650 from $610 and kept an “outperform” rating, a call that signals expectations for the stock to beat the broader market. The stock was last up 2.4% at $606.63, after swinging between $590.00 and $608.29 on volume of about 1.6 million shares. MarketScreener
Thermo Fisher Scientific Inc. (TMO) Stock Outlook: Latest News, Analyst Forecasts, and Key 2026 Catalysts (Dec. 25, 2025)

Thermo Fisher Scientific Inc. (TMO) Stock Outlook: Latest News, Analyst Forecasts, and Key 2026 Catalysts (Dec. 25, 2025)

December 25, 2025 — Thermo Fisher Scientific Inc. heads into the year-end holiday period with investors balancing three big themes: fresh institutional positioning revealed in new filings, steady analyst optimism on 2026 upside, and a strategy that blends targeted M&A with deeper bets on clinical research and data-driven drug development.
25 December 2025
Thermo Fisher Scientific (TMO) Stock After the Bell on Dec. 24, 2025: What Happened Today and What to Watch Before the Next Market Open

Thermo Fisher Scientific (TMO) Stock After the Bell on Dec. 24, 2025: What Happened Today and What to Watch Before the Next Market Open

Thermo Fisher Scientific Inc. wrapped up the shortened Christmas Eve session on Wednesday, December 24, 2025 with a muted move—exactly the kind of tape you’d expect when liquidity thins out ahead of a major U.S. market holiday. The stock finished the session around $579.12, down roughly 0.14% from the prior close, after trading in a narrow range through the day. StockAnalysis+1
25 December 2025
Thermo Fisher Scientific Stock (TMO) News Today: What’s Driving Shares, Analyst Forecasts, and Key Catalysts on Dec. 19, 2025

Thermo Fisher Scientific Stock (TMO) News Today: What’s Driving Shares, Analyst Forecasts, and Key Catalysts on Dec. 19, 2025

Thermo Fisher Scientific Inc. is back in the spotlight on Friday, December 19, 2025, as investors weigh a fresh set of operational updates, capital-return signals, and Wall Street forecasts. Shares were trading around $569.54, up about 1.27% on the day, giving the life sciences and diagnostics giant a market value near $218 billion.
19 December 2025
Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

WALTHAM, Mass. / Markets — December 18, 2025: Thermo Fisher Scientific Inc. is in focus Thursday as investors weigh a new Alzheimer’s real‑world evidence initiative from its PPD CorEvitas clinical registries business alongside a steady stream of Wall Street forecasts and valuation takes. Shares were trading around $561 in the afternoon, modestly lower on the day, after a 1.33% decline in Wednesday’s session. StockAnalysis+1
18 December 2025
Go toTop